Ambuja Cements (AMBUJACEM) — Corporate Action

Ambuja Cements received SEBI and NSE observation letters confirming no adverse observations on its proposed scheme to acquire Penna Cement Industries, clearing a key regulatory hurdle for the merger. The letters mandate full disclosure of legal matters, updated financials, and shareholder rationale before final approval. The transaction involves cash consideration of Rs. 321.50 per Penna share, reflecting a valuation uplift over prior estimates.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this corporate action affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 30 April 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 30 April 2025

TECHM Tech Mahindra Limited Financial Results RELIANCE Reliance Industries Limited Corporate Action SBIN State Bank of India Financial Results SBICARD SBI Cards and Payment Services Limited Financial Results TCS Tata Consultancy Services Limited Corporate Action VBL Varun Beverages Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.